Your search for replac returned 2192 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Drugs in the Pipeline remove

Your search for replac returned 2192 results

Sort Results:

Relevant Recent
Drugs in the Pipeline

Eliquis sNDA Accepted for Review for DVT Prophylaxis

The FDA has accepted Bristol-Myers Squibb's and Pfizer's supplemental New Drug Application for Eliquis (apixaban), an oral direct Factor Xa inhibitor for prophylaxis of deep vein thrombosis (DVT) following hip or knee replacement surgery.
Drugs in the Pipeline

Rare Neurologic Disorder Therapy Granted Orphan Drug Status

The Food and Drug Administration (FDA) has granted Orphan Drug designation to its investigational therapy RE-024 (phosphopantothenate replacement therapy; Retrophin), for the treatment of pantothenate kinase-associated neurodegeneration (PKAN).
Drugs in the Pipeline

FDA to Review Natpara BLA for Hypoparathyroidism

The FDA has accepted for review NPS Pharmaceuticals' Biologics License Application (BLA) for Natpara (recombinant human parathyroid hormone 1-84, rhPTH[1-84]) for the treatment of hypoparathyroidism.